Aplus Biotechnology Corporation Limited (6918.TWO)
- Previous Close
99.70 - Open
99.30 - Bid --
- Ask --
- Day's Range
99.20 - 99.90 - 52 Week Range
66.10 - 117.50 - Volume
28,251 - Avg. Volume
87,607 - Market Cap (intraday)
3.026B - Beta (5Y Monthly) --
- PE Ratio (TTM)
20.00 - EPS (TTM)
4.96 - Earnings Date --
- Forward Dividend & Yield 4.00 (4.01%)
- Ex-Dividend Date Apr 18, 2025
- 1y Target Est
--
Aplus Biotechnology Corporation Limited engages in the development of orthopedic trauma medical equipment products. The company is based in New Taipei City, Taiwan.
www.aplusbio.comRecent News: 6918.TWO
View MorePerformance Overview: 6918.TWO
Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6918.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6918.TWO
View MoreValuation Measures
Market Cap
3.03B
Enterprise Value
2.70B
Trailing P/E
19.12
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.85
Price/Book (mrq)
3.59
Enterprise Value/Revenue
3.42
Enterprise Value/EBITDA
11.94
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
4.96
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--